Dopharma strengthens position in Asia with registration Melovem® 30 mg/ml Injection in China

Raamsdonksveer, the Netherlands – November 7, 2023

Dopharma, a leading player in the veterinary pharmaceutical industry, is proud to announce the successful expansion of its business in Asia. Thanks to solid expertise, in-depth knowledge and years of experience, Dopharma has completed the registration process for its product Melovem® 30 mg/ml Injection in China.

The registration process, specifically for cattle, took five years. Within this period, Dopharma met all the requirements set by the Chinese authorities. An achievement that testifies to the company’s dedication to meet the stringent local standards of this growing market.

Unique registration in the Chinese market

Melovem® 30 mg/ml Injection is not the only authorised veterinary medicine with meloxicam as active substance. However, Dopharma is the only marketing authorisation holder with a concentration of 30 mg/ml. This unique concentration means livestock farmers need to administer a smaller volume. This is safer for both animal and operator. Meloxicam is also long-acting in cattle, which means that one administration is sufficient in most cases.

Committed to healthy livestock

In a country like China where milk production is booming, a ‘non-steroidal anti-inflammatory drug’ (NSAID) like Melovem® 30 mg/ml Injection, contributes to animal welfare and can be used as supportive treatment for respiratory infections, diarrhoea and mastitis.

This realisation is therefore fully in line with Dopharma’s strategic vision to enter new markets and contribute to global healthy livestock animal welfare.

For more information:
Wijnand de Bruijn
CEO Business
+31 162 58 20 00
[email protected]

About Dopharma

Originally a Dordrecht-based Dutch family-owned pharmaceutical company, we have been manufacturing and supplying veterinary drugs for livestock since 1969. Starting as a one-man business at the time, we have grown into an international company. Abroad, our products are sold through local affiliates and distributors in 80 countries worldwide.
Dopharma produces 95% of its veterinary drugs itself, using its own modern GMP-certified production lines. This way, we work together in a focused way on smart solutions for livestock farming to achieve the best results.

Our vision Healthy livestock farming enables healthy returns
Our mission Using our knowledge to continuously improve livestock farming
Our motto Working together for success
Our essence Healthy livestock, healthy food, healthy people